Biliary tract cancer
Showing 26 - 50 of >10,000
Pancreas Cancer Trial (mRNA expression)
Not yet recruiting
- Pancreas Cancer
- mRNA expression
- (no location specified)
Aug 8, 2022
Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)
Withdrawn
- Platinum-Sensitive Biliary Tract Cancer
- Cisplatin
- +4 more
- (no location specified)
May 27, 2022
Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)
Recruiting
- Biliary Tract Cancer
- Tumour and germline molecular profiling
-
Montréal, Quebec, CanadaMcGill University Health Centre
Nov 2, 2022
Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)
Recruiting
- Advanced Biliary Tract Cancer
- Envofolimab
- +3 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022
Biliary Tract Cancer, Cholangiocarcinoma Trial in Aachen, Frankfurt (Bintrafusp alfa)
Terminated
- Biliary Tract Cancer
- Cholangiocarcinoma
- Bintrafusp alfa
-
Aachen, Germany
- +1 more
May 17, 2022
Biliary Tract Cancer Trial in Goyang-si, Seoul (SMT-NK inj.+Pembrolizumab, Pembrolizumab)
Recruiting
- Biliary Tract Cancer
- SMT-NK inj.+Pembrolizumab
- Pembrolizumab
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +2 more
Jun 28, 2022
European Training Program for Robotic Liver Surgery (LIVEROBOT)
Not yet recruiting
- Liver Diseases
- +6 more
- European Multicentre Training Program for Robotic Liver Surgery
- (no location specified)
Feb 8, 2023
Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)
Active, not recruiting
- Biliary Tract Cancer
- Nivolumab
- +3 more
-
Ann Arbor, Michigan
- +4 more
Oct 6, 2022
Biliary Carcinoma Trial in Nanjing (Disitamab Vedotin combined with Zimberelizumab)
Recruiting
- Biliary Carcinoma
- Disitamab Vedotin combined with Zimberelizumab
-
Nanjing, Jiangsu, ChinaJiangsu Province Hospital
Sep 14, 2022
Gastrointestinal Cancer Trial in Hangzhou (Pemigatinib Pill)
Recruiting
- Gastrointestinal Cancer
- Pemigatinib Pill
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 26, 2022
Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,
Recruiting
- Biliary Tract Cancer (CCA)
- +4 more
- Durvalumab
- +2 more
-
Frankfurt am Main, GermanyKrankenhaus Nordwest
Jun 23, 2022
Advanced Biliary Tract Cancer Trial in Taipei (Lenvatinib Pill,Paclitaxel)
Recruiting
- Advanced Biliary Tract Cancer
- Lenvatinib Pill,Paclitaxel
-
Taipei, TaiwanTaiwan Cooperative Oncology Group, National Health Research Inst
Jul 27, 2022
Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)
Recruiting
- Biliary Tract Cancer
- Pemetrexed 500 MG
- Erlotinib
-
Seoul, Korea, Republic of
- +1 more
Jun 13, 2022
Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Biliary Tract Cancer
- +2 more
- Tumor Infiltrating Lymphocytes (TIL)
-
Pittsburgh, PennsylvaniaAllyson Welsch
Jul 21, 2022
Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)
Recruiting
- Biliary Tract Cancer
- DNA Damage Repair Deficiency
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 8, 2022
Biliary Tract Cancer Trial in Changchun (Lenvatinib, PD-1 inhibitors)
Recruiting
- Biliary Tract Cancer
- Lenvatinib
- PD-1 inhibitors
-
Changchun, Jilin, ChinaLiu Bo
Aug 18, 2022
Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Durvalumab
- +5 more
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 1, 2023
Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Germany, Spain, United Kingdom (Pembrolizumab, Cisplatin,
Active, not recruiting
- Biliary Tract Cancer
- +3 more
- Pembrolizumab
- +2 more
-
Leipzig, Germany
- +6 more
Jul 1, 2022
Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)
Not yet recruiting
- Pancreatic Neoplasms
- +2 more
- BI 907828
- (no location specified)
Aug 22, 2022
Incidental Gallbladder Carcinoma-Permanent Platform Including
Recruiting
- Biliary Tract Cancer
- Neoadjuvant, Adjuvant and 1st Line
-
Frankfurt, GermanyKrankenhaus Nordwest GmbH
Aug 3, 2022
Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)
Not yet recruiting
- Biliary Tract Cancer
- +3 more
- (no location specified)
Aug 16, 2022
Metastatic Pancreatic Cancer, Metastatic Biliary Tract Cancer Trial in Herlev (Nivolumab, Ipilimumab, Radiotherapy)
Active, not recruiting
- Metastatic Pancreatic Cancer
- Metastatic Biliary Tract Cancer
- Nivolumab
- +2 more
-
Herlev, DenmarkHerlev & Gentofte Hospital
Mar 29, 2022
Pancreatic Cancer, Biliary Tract Cancer Trial in Oslo, Stockholm (Physical exercise)
Recruiting
- Pancreatic Cancer
- Biliary Tract Cancer
- Physical exercise
-
Oslo, Norway
- +1 more
Mar 30, 2022
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023